Question: How Should I Monitor and Adjust the Clozapine Dose for My Patients Who Develop COVID and Could Benefit From Nirmatrelvir/Ritonavir?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)201-203
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume44
Issue number2
DOIs
StatePublished - Mar 1 2024

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Question: How Should I Monitor and Adjust the Clozapine Dose for My Patients Who Develop COVID and Could Benefit From Nirmatrelvir/Ritonavir?'. Together they form a unique fingerprint.

Cite this